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1. Severe anaphylactoid reactions have been reported in some patients treated with 
angiotensin converting enzyme (ACE) inhibitors during hemodialysis with a poly aery lonitrile 
(PAN) membrane. Generation of bradykinin via contact activation at the negatively charged 
membrane surface and reduced bradykinin breakdown due to A C E inhibition have been suggested 
as possible causes. This hypothesis was evaluated in the present study. 
2. PAN or cellulose dialyzer membranes were incubated with plasma at different 
concentrations of ACE inhibitor. The rate and extent of kinin accumulation was dependent on the 
A C E inhibitor concentration. 
3. Bradykinin levels were determined in "historical" plasma samples drawn from 
patients treated with A C E inhibitor at the onset of anaphylactoid reactions during hemodialysis with 
PAN dialyzers. The kinin levels were significantly higher (2.4 ± 0.05 pmol/ml) than in samples from 
a group of control patients (0.29 ± 0.02 pmol/ml). 
4. Plasma kinin levels were measured in patients who developed anaphylactoid reactions 
during dialysis with a PAN membrane though not being treated with A C E inhibitor. At the onset of 
the reaction, kinin levels increased to 2.1 pmol/ml in the line entering the dialyzer and to 10.5 pmol/ 
ml in the line leaving the dialyzer compared to not more than 0.12 pmol/ml upon dialysis with other 
membranes. 
5. These i n vitro and i n vivo results demonstrate that contact of blood with a polyacrylo-
nitrile membrane leads to the generation of kinins which accumulate if A C E is inhibited. It is very 
likely that kinin accumulation in the circulation is the cause of anaphylactoid reactions during 
hemodialysis with PAN membranes in patients treated with ACE inhibitors and, in some cases, in 
patients not receiving A C E inhibitor medication. 
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Introduction 
During hemodialysis there is extensive contact between blood and 
artificial membrane surfaces which in relatively rare cases evokes hypersensitiv-
ity reactions within the first few minutes of dialysis. Symptoms range from mild 
reactions with flushing, edema and dizziness to life-threatening reactions with 
severe bronchospasm, hypotension and cardiorespiratory arrest. Hypersensitivity 
to ethylene oxide (Grammer et al., 1984; Dolovich et al., 1984), complement 
activation (Hakim et al., 1984) and passage of microbial products across the 
membrane (Man et al., 1988) have been considered to be causes of anaphylactoid 
reactions. 
Recently, a new mechanism of severe anaphylactoid reactions occurring 
during hemodialysis with a polyacrylonitrile (PAN) membrane has been pro-
posed (Tielemans et al., 1990; Verresen et al., 1990). Most of the reactions 
occurred in patients treated with angiotensin converting enzyme (ACE) inhibitor. 
Data from several hemodialysis centers on this type of reaction were reviewed in 
a survey of 591 patients dialyzed with a PAN membrane; 72 of them were under 
treatment with A C E inhibitor, 41 of these developed anaphylactoid reactions 
(Parnes and Shapiro, 1991). In contrast, among the remaining 519 patients not 
receiving A C E inhibitor treatment, only two reactions occurred. In comparison, 
496 patients dialyzed with other membranes, mainly of the cellulose type, pre-
sented no reactions, even the 71 patients treated with ACE inhibitor. 
The association of ACE inhibitors with the PAN-related anaphylactoid 
reactions suggested the participation of bradykinin (Tielemans et al., 1990; 
Verresen et al., 1990) and consequently the "bradykinin hypothesis" was sug-
gested: i) plasma kallikrein released via contact activation by negative charges on 
the polyacrylonitrile membrane surface liberates bradykinin from high molecular 
weight kininogen; ii) as kininase II (=ACE) is inhibited by the A C E inhibitor the 
kinin released can accumulate in the circulation and cause the observed anaphy-
lactoid reactions. In order to evaluate this hypothesis we performed the i n v i t r o 
and i n v i v o studies described here. 
Material and Methods 
I n v i t r o studies 
Blood from healthy donors was used within 30 min after venipuncture. 
For studies on bradykinin release, citrated (0.38% citrate) or heparinized (5 U/ml) 
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plasma was used. Experiments on C5a generation or histamine release were 
carried out with heparinized whole blood (5 U/ml). The ACE inhibitor used was 
Captopril, and the endotoxin S a l m o n e l l a m i n n e s o t a (Re595, List, Campbell, CA, 
USA). 
Flat 32-cm2 membrane sheets of either cellulose (CEL), or polyacrylo-
nitrile (PAN) obtained from commercially available dialyzers were incubated in 
Petri dishes with 8.0 ml citrated human plasma or heparinized whole blood at 
37°C for up to 1 h under gentle shaking. Control experiments without membranes 
were performed in the same way. For kinin measurements, 0.2 ml plasma was 
removed at specific times, mixed with 1 ml ethanol and heated to 70°C for 10 min. 
After centrifugation the supernatant was removed and dried under vacuum. The 
kinin content of the residues was determined by radioimmunoassay (Fink et al., 
1985). 
des-Arg-C5a was determined by an enzyme immunoassay (Behring, 
Marburg, Germany) having a sensitivity of 0.2 ng/ml. Histamine was determined 
by a radioimmunoassay (Immunotech/Dianova, Hamburg, Germany), with a sen-
sitivity of 0.5 nM. 
S t a t i s t i c a l a n a l y s i s 
Each experiment was done three times, each time with blood from a 
different donor. All samples were measured in triplicate. The data sets of nine 
values per time point were evaluated by the Duncan multiple range test using the 
SAS software package. Mean values were considered significantly different 
when P<0.01. 
I n v i v o studies 
Study 1 . During the first few months of 1990 several patients of the 
dialysis center in Leuven who were under treatment with ACE inhibitor devel-
oped anaphylactoid reactions at the onset of dialysis with PAN dialyzers. During 
the anaphylactoid reactions blood samples were drawn into syringes containing 
potassium EDTA (1.5 mg/ml) from the lines entering the dialyzer and centrifuged 
within 10 min. Control blood samples were collected in the same way from 
patients without reactions on the PAN membrane and without ACE inhibitor 
treatment 5 min after the start of dialysis. All plasma samples were stored at -70°C. 
Kinin measurements were carried out in 1992. After thawing, plasma was mixed 
with an inhibitor cocktail (Shimamoto et al., 1988) (9:1 v/v) and 200 fû of this 
mixture was added to 800 fi\ ethanol at 0°C, kept 15 min at 4°C, and then heated 
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for 15 min at 70°C. After centrifugation the supernatant was removed and dried 
under a stream of air. 
In order to determine the effect of the sampling procedure on kinin 
generation, blood samples from nine patients dialyzed with PAN membranes 
without reactions and not taking A C E inhibitors were collected into an inhibitor 
cocktail and processed according to Shimamoto et al. (1988), and in parallel, 
additional samples were drawn into EDTA and processed as described above. 
The kinin content of all samples was measured by radioimmunoassay (Fink et al., 
1985). 
Study 2. A 26-year old woman not treated with A C E inhibitor developed 
two episodes of anaphylactoid reaction 3 to 5 min after starting hemodialysis with 
a PAN dialyzer, but not when a CEL or a high-flux polysulfone dialyzer was used. 
Blood samples were collected 5 min after the start of hemodialysis and processed 
for kinin determination (Shimamoto et al., 1988). 
Results and Discussion 
I n v i t r o studies 
Extending our previous studies (Lemke and Fink, 1992a,b), we under-
took a series of i n v i t r o experiments to investigate the possibility that the combi-
nation of the PAN dialyzers and Captopril therapy provokes anaphylactoid reac-
tions. We investigated the effect of a PAN membrane on the release of kinin upon 
incubation with plasma in the presence of ACE inhibitor as well as the possibility 
that microbial lipopolysaccharides (endotoxin) can contribute to kinin generation 
and that PAN/captopril might enhance complement activation or histamine re-
lease and, thus, eventually lead to adverse reactions. 
When plasma was incubated with a PAN hemodialyzer membrane in the 
presence of Captopril (0.1 ^g/ml), bradykinin levels increased from 27 to 2926 
fmol/ml after 15 min, whereas the values at 15 min for the CEL membrane and for 
the control without membrane were 275 and 33 fmol/ml, respectively (means, N = 
3 donors, P<0.01). The maximal kinin concentration and kinin stability in the 
incubation mixture were dependent on Captopril concentration (Figure 1). Endo-
toxin, when added to the incubation mixtures, had no effect on the rate or extent 
of kinin generation. 
A further possible cause of anaphylactoid reactions might be comple-
ment system activation. In the i n v i t r o system, however, PAN/captopril did not 
cause activation of the complement system. In contrast, CEL did cause activation 
of the complement system, but these membranes are not involved in A C E inhibi-
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Figure 1 - The rate and extent of kinin accumulation in plasma during incubation with a PAN 
membrane is dependent on the concentration of Captopril. Human plasma was incubated with a 32 
cm2 PAN membrane at 37°C in the presence of different concentrations of Captopril. Aliquots of 
plasma were removed and processed for the measurement of kinin by radioimmunoassay. 
tor-related patient reactions and have been used without complications for 
hemodialysis in patients who developed anaphylactoid reactions with the PAN 
membrane. 
In order to determine whether histamine release from basophils might 
be involved in the PAN-related reactions we incubated heparinized whole blood 
in the presence of 0.1 jug/ml Captopril. In the control and in the incubates with 
PAN or CEL membranes only a small histamine release of up to 5 pmol/ml was 
observed, whereas for a positive control, when anti-IgE was added the histamine 
concentration rose immediately to 80 pmol/ml. 
Taken together, the results of our i n v i t r o studies demonstrate that PAN 
causes a release of kinin, and in the presence of a sufficiently high concentration 
of ACE inhibitor kinin accumulates in the incubation medium because its inacti-
vation is inhibited. Our studies indirectly exclude the possibility that other factors 
such as histamine or complement, considered to be causes of anaphylactoid 
reactions, play a part in provoking the PAN/ACE inhibitor-related reactions. The 
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results of these and our previous studies (Lemke and Fink, 1992a,b) do not fully 
agree with results reported by Schulman et al. (1993) who used a somewhat 
different experimental approach. These authors incubated pieces of hollow fiber 
membranes with whole citrated blood and found a large increase of kinin concen-
tration within 5 min for PAN even when ACE inhibitors were omitted, whereas 
with CEL a slow, but finally also large increase was observed during the 1-h 
observation time. To explain the reason for the difference in relation to our results 
(i.e., an increase of kinin concentration in the absence of ACE inhibitor and a 
slow but significant kinin generation by CEL), we can only speculate that the 
properties of the surface hollow fiber membrane, though of the same material, 
may differ from that of flat sheet membranes. Another possibility is that the 
surface area of the 5-g pieces of hollow fiber membrane is much larger than that 
used by us, and/or the antibody used by Schulman et al. (1993) in the radioimmu-
noassay also detected degradation products of kinin. However, their results and 
ours are consistent in that both groups demonstrated that the PAN membrane 
causes a very rapid release of an amount of kinin i n v i t r o , which should be high 
enough to provoke anaphylactoid reactions in the i n v i v o situation. 
I n v i v o studies 
For ethical reasons it is impossible to perform a prospective clinical 
study on the use of PAN hemodialyzers in patients treated with ACE inhibitors. 
However, we could perform a retrospective study with plasma samples collected 
in 1990 from several patients who were treated with ACE inhibitor and developed 
anaphylactoid reactions at the onset of dialysis with a PAN membrane (Verresen 
et al., 1994) (Table 1, group I). The kinin levels (2392 ± 53 pmol/1) were about 
seven-fold higher than those of the control group II (350 ± 1 6 pmol/1). Since the 
samples were not obtained in a way that would optimally suppress kinin genera-
tion during blood collection and handling (kinin determination had not been 
planned at that time), the data were validated further by comparing kinin levels of 
samples prepared by the incorrect (group III, 250 ± 15 pmol/1) and the correct 
technique (Shimamoto et al., 1988) (group IV, 63 ± 8 pmol/1). Comparison of 
groups III and IV clearly demonstrates that an incorrect sampling technique 
causes elevated kinin plasma levels which, however, are within the same range as 
those of the control group II, whereas the kinin levels of patients with anaphylac-
toid reactions, group I, are by far too high to be explained by this artifactual kinin 
release during inappropriate sample handling. Comparison with the control groups 
clearly demonstrates that the high levels in group I indeed reflect generation of 
bradykinin during hemodialysis with PAN dialyzers, which accumulates in the 
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Table 1 - Plasma k i n i n levels i n patients with and without anaphylactoid reactions. 
All samples were obtained from the line entering the dialyzer either after the onset of the reaction or, 
for groups II-IV, 5 min after starting dialysis. Group I: patients under treatment with A C E inhibitor 
who developed an anaphylactoid reaction (AR) at the onset of hemodialysis with a PAN membrane. 
Group II: control patients without A C E inhibitor treatment and without AR but dialyzed with PAN. 
The blood samples of groups I and II were not drawn directly into an inhibitor cocktail (Shimamoto 
et al., 1988) and artefactually elevated kinin levels were expected. The effect of this incorrect 
sampling procedure on plasma kinin levels was studied in a control experiment in which blood 
samples from groups III and IV were drawn with and without using an inhibitor cocktail, respec-
tively. 
Groups 
I 
Patients with 
AR 
II 
Control 
III 
Control 
IV 
Control 
Number 9 9 9 9 
Sampling with inhibitor cocktail no no no yes 
Kinin concentration 
Mean ± SEM (pmol/1) 2392 ± 53 350 ± 16 250 ± 15 63 ± 8 
circulation because its break-
down is diminished by the 
A C E inhibitor. 
Very high plasma ki-
nin levels during hemodialysis 
with PAN membranes were 
observed in a 26-year old pa-
tient who developed anaphy-
lactoid reactions although not 
being treated with an ACE in-
hibitor (Table 2) (Verresen et 
al., 1993,1994). She remained 
symptom-free and had normal 
plasma levels of kinin during 
dialysis with C E L and 
polysulfone membranes. Ob-
viously, some special proper-
ties of the PAN membrane 
Table 2 - Plasma k i n i n levels (fmol/ml) before and d u r i n g 
hemodialysis of a patient not treated with A C E i n h i b i t o r 
who developed anaphylactoid reactions with P A N but not 
with other dialyzer membranes. 
Blood samples were collected from the lines entering, A, 
and leaving, V, the dialyzer into an inhibitor cocktail and 
processed (Shimamoto et al., 1988) for kinin determination 
by radioimmunoassay. 
0 min 5 min 
A 
5 min 
V 
PAN (1st episode) 212 2112 5280 
PAN (2nd episode) 76 2107 10468 
CEL (one treatment, 
no reaction) 0 36 0 
Polysulfone (one treatment, 29 0 123 
no reaction) 
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must be responsible for the bradykinin release, but in this case, the development 
of anaphylactoid reactions must be due to a hitherto unrecognized patient inabil-
ity to degrade kinin efficiently. A similar case was reported recently by Schaefer 
et al. (1993). 
In conclusion, the results of the i n v i t r o and i n v i v o studies described 
here support the "bradykinin hypothesis" (cf. Introduction), demonstrating that 
contact of blood with the PAN hemodialyzer membrane provokes a significant 
generation of kinin and that the presence of an ACE inhibitor can effectively 
block kinin degradation in plasma. I n v i v o , the accumulation of kinin in the 
circulation finally causes anaphylactoid reactions. Not all patients exposed to the 
combination of PAN dialyzer and ACE inhibitor developed anaphylactoid reac-
tions and, on the other hand, some patients who are treated with PAN but not with 
A C E inhibitor are occasionally affected. Therefore, one has to assume that 
factors other than blocking kinin degradation by ACE inhibition also play a role 
in this phenomenon. 
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